Adding Vaccine to Immunotherapy for Liver Cancer Shows Promise in Early Trial
TUESDAY, April 9, 2024 -- A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.The vaccine could help liver cancer patients...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | General Medicine | Immunotherapy | Liver | Study | Urology & Nephrology | Vaccines